Invex Therapeutics Ltd - ESG Rating & Company Profile powered by AI
This assessment of Invex Therapeutics Ltd uses data from across the internet as well as from available filings by Invex Therapeutics Ltd. Alternative corporations in the scoring peer group for Invex Therapeutics Ltd are displayed. The ESG rating covers 17 UN SDGs including: 'Gender Equality', 'Climate Action' and 'Peace, Justice & Strong Institutions'.
Invex Therapeutics Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Invex Therapeutics Ltd | 8.0 | High |
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Invex Therapeutics Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Invex Therapeutics Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Invex Therapeutics Ltd report the average age of the workforce?
Sign up for free to unlockDoes Invex Therapeutics Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Invex Therapeutics Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Invex Therapeutics Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Invex Therapeutics Ltd offer flexible work?
Sign up for free to unlockDoes Invex Therapeutics Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Invex Therapeutics Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Invex Therapeutics Ltd conduct supply chain audits?
Sign up for free to unlockDoes Invex Therapeutics Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Invex Therapeutics Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Invex Therapeutics Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Invex Therapeutics Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Invex Therapeutics Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Invex Therapeutics Ltd disclose water use targets?
Sign up for free to unlockDoes Invex Therapeutics Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Invex Therapeutics Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Invex Therapeutics Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Invex Therapeutics Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Invex Therapeutics Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Invex Therapeutics Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Invex Therapeutics Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Invex Therapeutics Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Invex Therapeutics Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Invex Therapeutics Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Invex Therapeutics Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Invex Therapeutics Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Invex Therapeutics Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Invex Therapeutics Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Invex Therapeutics Ltd disclose its waste policy?
Sign up for free to unlockDoes Invex Therapeutics Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Invex Therapeutics Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Invex Therapeutics Ltd disclose energy use targets?
Sign up for free to unlockDoes Invex Therapeutics Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Invex Therapeutics Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Invex Therapeutics Ltd
These potential risks are based on the size, segment and geographies of the company.
Invex Therapeutics Ltd, a biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia. It is involved in developing Exenatide, a treatment for neurological conditions derived from or involving raised intracranial pressure, such as idiopathic intracranial hypertension, acute stroke, and traumatic brain injury that has completed Phase II clinical trial. The company was incorporated in 2019 and is based in Perth, Australia.